BTBD16: A Drug Target / Disease Biomarker (G118663)

Target Name: BTBD16

NCBI ID: G118663

BTBD16

BTBD16: A Drug Target / Disease Biomarker

BTBD16 is a protein that is expressed in a variety of tissues throughout the body, including the brain, spinal cord, and peripheral tissues. It is a member of the BTBD family of proteins, which are known for their role in cell signaling and inflammation. In recent years, BTBD16 has gained significant attention as a potential drug target due to its involvement in a variety of neurological and psychiatric disorders.

The BTBD16 protein is composed of 194 amino acid residues and has a calculated molecular weight of 21.1 kDa. It is expressed in a variety of tissues, including the brain, spinal cord, and peripheral tissues. It is highly expressed in the brain, with the highest levels of expression found in the prefrontal cortex and the cerebellum. BTBD16 is also expressed in other tissues, including the lungs, liver, and muscle.

BTBD16 is a member of the BTBD family of proteins, which are known for their role in cell signaling and inflammation. The BTBD family includes several other proteins, including BTBD2, BTBD3, and BTBD4. These proteins are involved in a variety of cellular processes, including cell signaling, cytoskeletal organization, and inflammation.

In recent years, BTBD16 has gained significant attention as a potential drug target due to its involvement in a variety of neurological and psychiatric disorders. For example, BTBD16 has been shown to be involved in the development and progression of several neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

In addition to its involvement in neurological disorders, BTBD16 has also been shown to be involved in the development and progression of psychiatric disorders. For example, BTBD16 has been shown to be involved in the development of depression and anxiety disorders.

BTBD16 is also involved in several other physiological processes in the body. For example, it is involved in the regulation of cell signaling, and it is thought to play a role in the development and maintenance of the blood-brain barrier.

In conclusion, BTBD16 is a protein that is expressed in a variety of tissues throughout the body and is involved in a variety of cellular processes. Its involvement in the development and progression of neurological and psychiatric disorders makes it a potential drug target. Further research is needed to fully understand the role of BTBD16 in these processes and to develop effective treatments for these disorders.

Protein Name: BTB Domain Containing 16

The "BTBD16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BTBD16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets